BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 22259180)

  • 21. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
    Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
    Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
    Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
    J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
    Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
    J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical staining characteristics of low-grade adenosquamous carcinoma of the breast.
    Kawaguchi K; Shin SJ
    Am J Surg Pathol; 2012 Jul; 36(7):1009-20. PubMed ID: 22446941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phyllodes tumors and fibroadenoma common beginning and different ending.
    Oprić S; Oprić D; Gugić D; Granić M
    Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
    Kocová L; Skálová A; Fakan F; Rousarová M
    Pathol Res Pract; 1998; 194(2):97-104. PubMed ID: 9584322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multinucleated stromal giant cells in mammary phyllodes tumours.
    Tse GM; Law BK; Chan KF; Mas TK
    Pathology; 2001 May; 33(2):153-6. PubMed ID: 11358046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phyllodes tumor of the prostate: long-term followup study of 23 cases.
    Bostwick DG; Hossain D; Qian J; Neumann RM; Yang P; Young RH; di Sant'agnese PA; Jones EC
    J Urol; 2004 Sep; 172(3):894-9. PubMed ID: 15310992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic stromal histomorphology in fibroepithelial breast lesions: a fresh perspective.
    Aiyer HM; Jain M; Thomas S; Logani KB
    Indian J Pathol Microbiol; 2000 Jan; 43(1):5-12. PubMed ID: 12583412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem.
    Krishnamurthy S; Ashfaq R; Shin HJ; Sneige N
    Cancer; 2000 Dec; 90(6):342-9. PubMed ID: 11156517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
    Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
    J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS; Tamsen A
    Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision?
    Jacobs TW; Chen YY; Guinee DG; Holden JA; Cha I; Bauermeister DE; Hashimoto B; Wolverton D; Hartzog G
    Am J Clin Pathol; 2005 Sep; 124(3):342-54. PubMed ID: 16191502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
    Sawyer EJ; Hanby AM; Rowan AJ; Gillett CE; Thomas RE; Poulsom R; Lakhani SR; Ellis IO; Ellis P; Tomlinson IP
    J Pathol; 2002 Apr; 196(4):437-44. PubMed ID: 11920740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
    Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
    Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
    Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients.
    Adem C; Reynolds C; Adlakha H; Roche PC; Nascimento AG
    Histopathology; 2002 Jun; 40(6):556-62. PubMed ID: 12047767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
    Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
    J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.
    Moore T; Lee AH
    Histopathology; 2001 Jan; 38(1):62-7. PubMed ID: 11135048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.